Review
Open access
Sep 2026
Mucus-penetrating nanocarriers for the enhanced oral delivery of antibody drugs.
Monoclonal antibodies have transformed the treatment of cancer, autoimmune and inflammatory diseases, and other chronic conditions due to their high target specificity and favorable therapeutic profiles. However, nearly all approved antibody therapies require parenteral administration because the gastrointestinal tract...
Mireia Del Valle, Ainhoa Huidobro, Miriam Arellano et al.
· Nanomedicine · 0 citations